A confirmed case of SARS-CoV-2 Delta, also known as lineage B.1.617.2, has been discovered by the Nigeria Centre for Disease Control (NCDC).
The mutation was discovered in a traveler to Nigeria, according to the NCDC’s head of communications, Dr. Yahya Disu, following the normal travel test required of all international travelers and genomic sequencing at the NCDC National Reference Laboratory in Abuja.
Also in Newzandar News: I Am Madam Due Process – Lauretta Onochie Talks About Being After Her Nomination As INEC Commissioner
Because of its heightened transmissibility, the World Health Organization (WHO) has designated the Delta variation as a variant of concern, according to Disu.
”The variant has been detected in over 90 countries and is expected to spread to more countries. The variant has also been linked to a surge in cases in countries where it is the dominant strain in circulation. There are ongoing studies to understand the impact of the variant on existing vaccines and therapeutics.
As part of Nigeria’s COVID-19 response, NCDC has been working with the Nigerian Institute of Medical Research (NIMR), African Centre for Genomics of Infectious Diseases (ACEGID), and other laboratories within the national network, to carry out genomic sequencing. This is to enable the detection of variants of concern, and initiate response activities. All data on variants from Nigeria have been published on GISAID, a global mechanism for sharing sequencing data. Given the global risk of spread of the Delta variant, positive samples from international travelers to Nigeria are sequenced regularly.”the statement further read
”Additionally, states are urged to ensure sample collection and testing for COVID-19 is accessible to the public. Public settings such as schools with accommodation facilities, workplaces and camps should utilise the approved Antigen-based Rapid Diagnostic Test (RDT) for rapid testing of their population.”